Fig. 2
From: Community-based molecular and serological surveillance of subclinical malaria in Myanmar
Prevalence of P. falciparum and P. vivax infection and levels and seroprevalence of anti-P. falciparum and P. vivax IgG by month over the study period. Prevalence of P. falciparum (a, b) and P. vivax (c, d) infection and median IgG level (a, c) and seroprevalence (95%CI) (b, d) IgG by month over the study period. The high transmission season is shown in grey and months marked with an asterisk